How Language Barriers in Clinical Trials Affect Recruitment and Participation
- Shawn Thomas
- 6 minutes read
Language can influence nearly every stage of a participant’s clinical trial journey. Language barriers in clinical trials may affect whether someone sees a study opportunity, understands eligibility questions, completes informed consent, follows visit instructions, reports symptoms accurately, or remains engaged over time. A large analysis of 14,367 U.S. interventional trials registered between January 2019 and December 2020 found that 18.98% explicitly required participants to read, speak, or understand English, while only 2.71% specifically mentioned accommodation through translation into another language.
Addressing these barriers is not simply a matter of translating a consent form. Effective language access requires planning across recruitment, screening, informed consent, study visits, participant communication, and long-term follow-up. Recent work on clinical trial language support similarly emphasizes that translation and interpretation need to be considered across the entire trial lifecycle rather than only at enrollment.
Language Barriers in Clinical Trials Can Begin Before Screening
Language access starts with how potential participants first encounter a study. Recruitment advertisements, study websites, referral materials, call-center scripts, and initial outreach can unintentionally narrow the recruitment pool when they are available only in English or use terminology that is difficult to understand.
The issue is broader than literal translation. Materials also need to communicate the study purpose, time commitment, major procedures, and next steps in language that participants can understand. Its important to have understandable, culturally appropriate communication rather than relying on technical terminology.
For clinical operations teams, this means identifying likely language needs before recruitment launches. Sites serving multilingual communities may require translated outreach materials, bilingual staff, or qualified interpreters available during initial conversations. Planning these resources after referrals begin can create scheduling delays and inconsistent participant experiences. Site-level research has found that limited funding, translation availability, and interpreter availability can all become practical barriers to enrolling people who speak languages other than English.
A useful workflow might look like this: a Spanish-speaking prospective participant responds to a recruitment campaign, selects Spanish as a preferred language, receives the appropriate study information, and is connected with qualified language support before detailed screening begins. Language preference becomes part of the operational workflow rather than an issue discovered at the consent appointment.
Translation and Interpretation Serve Different Purposes
Translation and interpretation are related but distinct functions.
Translation converts written information from one language to another. In clinical research, this can include recruitment materials, consent documents, questionnaires, visit instructions, diaries, reminders, and other participant-facing materials.
Interpretation supports spoken communication between people using different languages. It may be required during screening calls, consent discussions, study visits, follow-up conversations, or safety-related communications.
Both require attention to accuracy and context. A translated document cannot replace a real-time conversation when participants have questions, and an interpreter cannot compensate for missing translated materials that a participant needs to reference later.
When non-English-speaking participants are expected to enroll, informed consent documentation must be presented in language understandable to the participant. U.S. regulations also permit specific short-form consent procedures in appropriate circumstances, but those procedures require defined documentation, witness, interpretation, and IRB processes rather than informal ad hoc translation.
Sponsors and sites therefore benefit from defining language workflows before enrollment begins, including who requests translations, how translated materials are reviewed, how interpreters are scheduled, and how language support is documented.
Informed Consent Requires Comprehension, Not Just Translation
Providing a translated informed consent form does not by itself demonstrate that a participant understands the study.
Consent is a communication process in which prospective participants should have sufficient time to review study information, ask questions, consider the risks and burdens of participation, and decide voluntarily whether to enroll. Current Good Clinical Practice guidance reinforces that participants should have an opportunity to ask questions and receive satisfactory answers before consenting.
Comprehension can be especially important when protocols involve complicated visit schedules, randomization, unfamiliar procedures, investigational treatments, or significant participant responsibilities.
Interactive approaches can help research teams identify misunderstandings. For example, a participant might be asked to explain in their own words what will happen at the next visit or what they should do if they experience a particular problem. Evidence from informed-consent research suggests that interactive methods such as teach-back and test-and-feedback can improve comprehension compared with passive information delivery alone.
This distinction makes the operational goal clearer: the objective is not merely to produce translated paperwork. It is to create a consent process in which participants can meaningfully understand and discuss the study.
Participant Communication Must Continue After Enrollment
Language support should not end once a consent form is signed.
Participants may later receive appointment reminders, preparation instructions, questionnaires, medication or device guidance, protocol updates, re-consent documents, and requests for follow-up information. If these communications become less accessible after enrollment, misunderstandings can reappear and participation may become more difficult.
For example, a participant who successfully completes consent with an interpreter may still struggle if subsequent scheduling calls, electronic questionnaires, or visit instructions are provided only in English. Another participant may understand routine study visits but require interpretation when discussing a new adverse event or a protocol change.
Recent clinical-trial language-access research recommends maintaining interpretation and translation resources throughout trial participation, monitoring language needs, and recording whether language-related issues contribute to reduced participation or withdrawal.
A practical operational model can therefore include a participant’s preferred language within referral and engagement workflows, interpreter requirements within visit scheduling, translated communications where appropriate, and clear escalation pathways when a participant needs additional support.
Building Language Access Into Clinical Trial Operations
Reducing language barriers requires coordination among sponsors, CROs, investigative sites, ethics committees, recruitment teams, and participant-support functions. Not every study can support every language, and some protocols may have legitimate study-specific linguistic requirements. However, language proficiency should not automatically become an exclusion criterion when operational solutions can reasonably support participation.
Operational planning can begin by identifying languages common within target recruitment populations, budgeting for translation and interpretation, establishing quality-control processes, training site teams on approved workflows, and tracking language-related recruitment and retention data.
A stronger operational approach goes further by treating language access as a continuous participant-journey issue, from the first advertisement through screening, informed consent, visits, re-consent, and final follow-up.
For sponsors and CROs trying to improve recruitment and participant experience, accessible communication is therefore not a standalone translation project. It is part of trial design and execution. When language needs are anticipated early and incorporated into workflows, sites are better prepared to communicate consistently with participants throughout the study.